A twenty-first century research agenda for polycystic ovary syndrome

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 20, Issue 2, 2006, Pages 331-336

  Legro, Richard S ^a   Azziz, Ricardo ^b   Giudice, Linda ^c  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

diagnosis; evidence based; polycystic ovary syndrome; research; treatment

Indexed keywords

ANTIANDROGEN; CLOMIFENE; CYPROTERONE ACETATE; DEXAMETHASONE; ENDOCRINE DISRUPTOR; ESTRADIOL; FOLLITROPIN; HUMAN MENOPAUSAL GONADOTROPIN; METFORMIN; ORAL CONTRACEPTIVE AGENT; PLACEBO; SPIRONOLACTONE;

ANOVULATION; BLOOD CLOTTING DISORDER; CARDIOVASCULAR DISEASE; CLINICAL RESEARCH; CLINICAL TRIAL; DISEASE COURSE; ENDOMETRIUM CANCER; EVIDENCE BASED PRACTICE; FEMALE; FEMALE INFERTILITY; GENETIC RISK; HIRSUTISM; HUMAN; HYPERANDROGENISM; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PHENOTYPE; POSTMENOPAUSE; PRECOCIOUS PUBERTY; REVIEW; RISK BENEFIT ANALYSIS; TREATMENT RESPONSE;

EVIDENCE-BASED MEDICINE; FEMALE; FORECASTING; HUMANS; HYPERANDROGENISM; POLYCYSTIC OVARY SYNDROME;

EID: 33744941083     PISSN: 1521690X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beem.2006.03.001     Document Type: Review

References (8)

1. Legro RS, Myess E. Swrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome? Hum Reprod 2004 Aug; 19(8): 1697-704. Epub 2004 June 10.
2. Bayram N., van Wely M., and van der Veen F. Pulsatile gonadotrophin releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database of Systematic Reviews 1 (2004) CD000412
3. Hughes E., Collins J., and Vandekerckhove P. Gonadotrophin-releasing hormone analogue as an adjunct to gonadotropin therapy for clomiphene-resistant polycystic ovarian syndrome. Cochrane Database of Systematic Reviews 2 (2000) CD000097 [Review] [3 refs] [computer file]
4. Farquhar C., Lee O., Toomath R., and Jepson R. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database of Systematic Reviews 4 (2003) CD000194
5. Van der Spuy Z.M., and le Roux P.A. Cyproterone acetate for hirsutism. Cochrane Database of Systematic Reviews 4 (2003) CD001125
6. Beck J., Boothroyd C., Proctor M., et al. Oral anti-oestrogens and medical adjuncts for subfertility associated with anovulation. Cochrane Database of Systematic Reviews 1 (2005) CD002249
7. Lord J.M., Flight I.H., and Norman R.J. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, d-chiro-inositol) for polycystic ovary syndrome. Cochrane Database of Systematic Reviews 3 (2003) CD003053
8. Hughes E., Collins J., and Vandekerckhove P. Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotropin for clomiphene-resistant polycystic ovary syndrome. Cochrane Database of Systematic Reviews 2 (2000) CD000087 [Review] [6 refs] [computer file]